Eksperimental'naia i klinicheskaia farmakologiia 1994-01-01

[Interspecific differences in kemantan pharmacokinetics].

S S Boĭko, V P Zherdev, N A Kisliak, B M Piatin, N V Klimova, P V Glan, A A Dvorianinov

Index: Eksp. Klin. Farmakol. 57(6) , 48-50, (1994)

Full Text: HTML

Abstract

The pharmacokinetics of the new immunostimulant kemantane, adamantane derivative, used in two species of animals (rats and rabbits) and man was studied. There were significant differences in the pharmacokinetics of kemantane and its active metabolite--adamantane-1,4-diol between the species.

Related Compounds

  • 5-Hydroxy-2-adaman...

Related Articles:

[Kemantane pharmacokinetics in rats].

1990-11-01

[Biull. Eksp. Biol. Med. 110(11) , 501-3, (1990)]

[The clinical pharmacokinetics of kemantane].

1991-01-01

[Farmakol. Toksikol. 54(1) , 57-9, (1991)]

[Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis].

1991-01-01

[Probl. Tuberk. (6) , 23-6, (1991)]

Effect of adamantanone derivative possessing anti-HIV properties on the redox processes in the cytochrome P-450 system.

2001-01-01

[Dokl. Biochem. Biophys. 378 , 210-3, (2001)]

[The effect of kemantane on T-helpers and T-suppressors].

1991-09-01

[Zh. Mikrobiol. Epidemiol. Immunobiol. (9) , 66-7, (1991)]

More Articles...